Viatris Inc (VTRS) stock

VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3010% below fair value

$20.82+0.15 (+0.73%)

Close on Nov 13, 2026Market cap $23.91BP/E –Yield 2.31%

Viatris EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -$3.00. The highest annual figure on record is $1.71 in fiscal 2022.

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$3.00	–
FY2024	Dec 31, 2024	-$0.53	-1160.0%
FY2023	Dec 31, 2023	$0.05	-97.1%
FY2022	Dec 31, 2022	$1.71	–
FY2021	Dec 31, 2021	-$1.05	–
FY2020	Dec 31, 2020	-$1.11	-3800.0%
FY2019	Dec 31, 2019	$0.03	-95.6%
FY2018	Dec 31, 2018	$0.68	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$0.28	–
Q2 FY2026	Jun 30, 2026	-$0.10	–
Q1 FY2026	Mar 31, 2026	$0.15	+87.5%
Q3 FY2025	Sep 30, 2025	-$0.11	–
Q2 FY2025	Jun 30, 2025	$0.00	-100.0%
Q1 FY2025	Mar 31, 2025	-$2.55	-1044.4%
Q3 FY2024	Sep 30, 2024	$0.08	-63.6%
Q2 FY2024	Jun 30, 2024	-$0.27	-242.1%
Q1 FY2024	Mar 31, 2024	$0.09	-69.0%
Q3 FY2023	Sep 30, 2023	$0.27	+3.8%
Q2 FY2023	Jun 30, 2023	$0.22	-33.3%
Q1 FY2023	Mar 31, 2023	$0.19	-26.9%
Q3 FY2022	Sep 30, 2022	$0.29	–
Q2 FY2022	Jun 30, 2022	$0.26	–
Q1 FY2022	Mar 31, 2022	$0.33	-8.3%
Q3 FY2021	Sep 30, 2021	$0.26	+225.0%
Q2 FY2021	Jun 30, 2021	-$0.23	-675.0%
Q1 FY2021	Mar 31, 2021	-$0.86	–
Q3 FY2020	Sep 30, 2020	$0.36	–
Q2 FY2020	Jun 30, 2020	$0.08	–
Q1 FY2020	Mar 31, 2020	$0.04	–
Q3 FY2019	Sep 29, 2019	$0.00	–
Q2 FY2019	Jun 30, 2019	$0.00	–